From Oxytocin to Ozempic: The Three Kinds of Peptides Running Women’s Health
Oxytocin and the injectable your patient ordered online are both “peptides.” That one word is doing a lot of dishonest work. This series takes it apart.
Peptides in Women’s Health · Part 1 of 7
A seven-part series on the peptides that already shape fertility, pregnancy, and menopause, and the booming peptide market that runs years ahead of the evidence.
One word covers the oxytocin running through an IV in the delivery room and the vial of “healing peptide” your patient ordered online last month. The FDA defines a peptide as any chain of 40 amino acids or fewer.1 The definition is honest. Most of the marketing built on top of it is not.
Peptides are short strings of amino acids. Many of the body’s own signals are peptides. The hormone that starts labor is a peptide. So is the one that drives ovulation, and the one that tells your brain you are full. That is why peptides are easy to sell. A clinic can say the body makes this naturally and be telling the truth while selling you something that has never been tested in a pregnant woman.
The honest way to understand peptides in women’s health is to sort them into three groups, because they are not one thing.
The first group is established peptide drugs. Oxytocin, to start labor and to stop bleeding after birth. Carbetocin, a longer-lasting version that the World Health Organization added to its essential medicines list partly because it does not need refrigeration.3 The GnRH-based drugs that run IVF cycles and treat endometriosis. GLP-1 drugs like semaglutide. These have known mechanisms, regulated manufacturing, and clinical trials behind them.
The second group is the body’s own peptides. GnRH and kisspeptin in the brain, oxytocin, insulin, the peptides the placenta makes in pregnancy. These run the female reproductive system. Some have become drug targets. Most are simply how the body works.
The third group is the commercial market. BPC-157, ipamorelin, CJC-1295, thymosin alpha-1, and a long list of others. They are sold for healing, anti-aging, fat loss, and hormone balance. For fertility, pregnancy, and menopause, this group has little or no human safety data. The FDA has flagged several of these ingredients as compounds that may carry significant safety risks.2
Here is what is at stake. Peptides are not fringe medicine. They already sit at the center of women’s health. But the peptide clinic market has run years ahead of the evidence, and the gap is widest exactly where the danger is greatest: in women who are pregnant, trying to conceive, or moving through menopause.
Paid subscribers continue below.
